enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Syros (SYRS) Up on FDA's Orphan Tag for Pancreatic Cancer Drug

   www.aol.com/news/syros-syrs-fdas-orphan-tag...

   Syros Pharmaceuticals (SYRS) receives Orphan Drug designation from the FDA for its pipeline candidate AY-5609 being developed for treating metastatic pancreatic cancer. Stock up.

3. FOLFIRINOX - Wikipedia

   en.wikipedia.org/wiki/FOLFIRINOX

   FOLFIRINOX is a chemotherapy regimen for treatment of advanced pancreatic cancer. It is made up of the following four drugs: It is made up of the following four drugs: FOL – folinic acid (leucovorin), a vitamin B derivative that enhances the effects of 5-fluorouracil (5-FU); [ 1 ] [ 2 ]

4. Halozyme - Wikipedia

   en.wikipedia.org/wiki/Halozyme

   The company is in various phases of clinical trials with PEGPH20 across multiple solid tumor types, including pancreatic cancer, non-small cell lung cancer (NSCLC), and gastric cancer, to test the drug's safety and efficacy. [3] Halozyme has one FDA approved product (Hylenex recombinant, hyaluronidase human injection [4] [5]).

5. Gemcitabine - Wikipedia

   en.wikipedia.org/wiki/Gemcitabine

   The pancreatic cancer trials found that gemcitabine increased one-year survival rate significantly, and it was approved in the UK in 1995 [11] and approved by the FDA in 1996 for pancreatic cancers. [5] In 1998, gemcitabine received FDA approval for treating non-small cell lung cancer and in 2004, it was approved for metastatic breast cancer. [5]

6. Merus Scores Its First FDA Approval For Lung Cancer Drug - AOL

   www.aol.com/merus-scores-first-fda-approval...

   On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell ...

7. FDA approves drug for treating pancreatic cancer - AOL

   www.aol.com/news/fda-approves-drug-treating...

   For premium support please call: 800-290-4726 more ways to reach us

8. Fast track (FDA) - Wikipedia

   en.wikipedia.org/wiki/Fast_track_(FDA)

   Once a drug receives fast track designation, early and frequent communication between the FDA and a drug company is encouraged throughout the entire drug development and review process. The frequency of communication assures that questions and issues are resolved quickly, often leading to earlier drug approval and access by patients.

9. New Pancreatic Cancer Drug an FDA Priority - AOL

   www.aol.com/2013/05/26/new-pancreatic-cancer...

   The FDA has granted Celgene's abraxane priority review as a first-line treatment for advanced pancreatic cancer, a move that shortens the normal review period by four months. In this video, health ...